LEF1 and glioblastoma: Other studies have also confirmed that LEF1-AS1 was abnormally expressed in GBM, and the 5-year OS period of GBM patients with high LEF1-AS1 expression was significantly shortened (p < 0.0001) (Wang et al., 2017).